Cieślewicz G, Gondorowicz K, Grzelewska-Rzymowska I, Rozniecki J
Oddziału Ftizjopneumonologii Kliniki Pneumonologii i Alergologii IMW AM w Lodzi.
Pneumonol Alergol Pol. 1995;63(5-6):281-5.
The aim of this study was to assess the duration of Loratadine effect on histamine H1 receptor in the airway. Six patients with mild or moderate asthma were examined. Bronchial reactivity to histamine was measured according to Cockcroft. The significant blockade of histamine H1 receptors in airway was observed from the 2nd day when 10 mg of Lo was given daily. The maximal protection with 10 mg doses was observed after 3-4 days. After another 5-6 days without Loratadine bronchial responsiveness return to the initial values. Single dose of 30 mg Loratadine given better protection against histamine bronchoconstriction than 10 mg given for 5 days. This effect was observed as early as 60 minutes after administration of Loratadine.
本研究的目的是评估氯雷他定对气道中组胺H1受体的作用持续时间。对6例轻度或中度哮喘患者进行了检查。根据科克罗夫特方法测量支气管对组胺的反应性。当每天给予10mg氯雷他定时,从第2天起观察到气道中组胺H1受体的显著阻断。给予10mg剂量后3 - 4天观察到最大保护作用。在停用氯雷他定另外5 - 6天后,支气管反应性恢复到初始值。单次给予30mg氯雷他定比连续5天给予10mg能更好地预防组胺引起的支气管收缩。在给予氯雷他定后60分钟就观察到了这种效果。